DLD Asset Management, LP

SEC CIK: 0001578299
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by DLD Asset Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of CLDX by DLD Asset Management, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−36,000−100.0%	Sold out	Holders
Q2 2022	36,000	$971.0K	0.1%	+28,300+367.5%	Added	Holders
Q1 2022	7,700	$262.0K	<0.1%	+7,700	New	Holders